Viatris Inc Cash Flow Conversion Efficiency
Viatris Inc cash flow conversion efficiency. Based on the latest financial reports, Viatris Inc (VTRS) has a cash flow conversion efficiency ratio of 0.027x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($381.80 Million) by net assets ($14.26 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Viatris Inc (1985–2025)
Cash flow conversion efficiency of Viatris Inc from 1985 to 2025. This chart illustrates how Viatris Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Viatris Inc for real-time trading data and today's change.
Viatris Inc Cash Flow Conversion Ratio Explained
Viatris Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Viatris Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viatris Inc ranked by their cash flow conversion efficiency. Also see Viatris Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Omv Petrom S.A
RO:SNP
|
0.052x |
|
Avic Shenyang Aircraft Co Ltd
SHG:600760
|
-0.203x |
|
Huatai Securities Co Ltd
SHG:601688
|
0.170x |
|
Credo Technology Group Holding Ltd
NASDAQ:CRDO
|
0.033x |
|
PERNOD RIC. SA SP.ADR 1/5
F:PER0
|
N/A |
|
Fortive Corp
NYSE:FTV
|
0.047x |
|
mBank SA
WAR:MBK
|
-0.258x |
|
China Coal Energy Co Ltd
SHG:601898
|
0.061x |
Annual Cash Flow Conversion Efficiency for Viatris Inc (1985–2025)
The table below shows the annual cash flow conversion efficiency of Viatris Inc from 1985 to 2025. Review Viatris Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $14.71 Billion | $2.32 Billion | 0.157x | +27.39% |
| 2024-12-31 | $18.64 Billion | $2.30 Billion | 0.124x | -9.66% |
| 2023-12-31 | $20.47 Billion | $2.80 Billion | 0.137x | -2.38% |
| 2022-12-31 | $21.07 Billion | $2.95 Billion | 0.140x | -4.82% |
| 2021-12-31 | $20.49 Billion | $3.02 Billion | 0.147x | +174.34% |
| 2020-12-31 | $22.95 Billion | $1.23 Billion | 0.054x | -64.64% |
| 2019-12-31 | $11.88 Billion | $1.80 Billion | 0.152x | -21.14% |
| 2018-12-31 | $12.17 Billion | $2.34 Billion | 0.192x | +24.04% |
| 2017-12-31 | $13.31 Billion | $2.06 Billion | 0.155x | -15.74% |
| 2016-12-31 | $11.12 Billion | $2.05 Billion | 0.184x | -10.47% |
| 2015-12-31 | $9.77 Billion | $2.01 Billion | 0.206x | -33.61% |
| 2014-12-31 | $3.28 Billion | $1.01 Billion | 0.310x | -17.14% |
| 2013-12-31 | $2.96 Billion | $1.11 Billion | 0.374x | +32.20% |
| 2012-12-31 | $3.36 Billion | $949.02 Million | 0.283x | +37.58% |
| 2011-12-31 | $3.50 Billion | $720.42 Million | 0.206x | -20.21% |
| 2010-12-31 | $3.62 Billion | $931.40 Million | 0.258x | +33.91% |
| 2009-12-31 | $3.15 Billion | $605.08 Million | 0.192x | +39.46% |
| 2008-12-31 | $2.79 Billion | $384.45 Million | 0.138x | +182.81% |
| 2007-12-31 | $3.44 Billion | $167.69 Million | 0.049x | -78.85% |
| 2006-12-31 | $1.69 Billion | $390.19 Million | 0.231x | -56.40% |
| 2005-12-31 | $787.65 Million | $416.56 Million | 0.529x | +379.23% |
| 2004-12-31 | $1.85 Billion | $203.71 Million | 0.110x | -18.80% |
| 2003-12-31 | $1.66 Billion | $225.58 Million | 0.136x | -37.23% |
| 2002-12-31 | $1.45 Billion | $313.14 Million | 0.217x | -12.37% |
| 2001-12-31 | $1.40 Billion | $346.47 Million | 0.247x | +317.55% |
| 2000-12-31 | $1.13 Billion | $67.02 Million | 0.059x | -40.25% |
| 1999-12-31 | $1.20 Billion | $119.22 Million | 0.099x | -35.76% |
| 1998-12-31 | $1.06 Billion | $163.40 Million | 0.154x | +117.79% |
| 1997-12-31 | $744.50 Million | $52.70 Million | 0.071x | +0.42% |
| 1996-12-31 | $659.70 Million | $46.50 Million | 0.070x | -42.53% |
| 1995-12-31 | $616.40 Million | $75.60 Million | 0.123x | -56.63% |
| 1994-12-31 | $482.70 Million | $136.50 Million | 0.283x | +201.85% |
| 1993-12-31 | $380.00 Million | $35.60 Million | 0.094x | -59.40% |
| 1992-12-31 | $296.00 Million | $68.30 Million | 0.231x | +3.43% |
| 1991-12-31 | $203.50 Million | $45.40 Million | 0.223x | -12.98% |
| 1990-12-31 | $153.30 Million | $39.30 Million | 0.256x | +71.63% |
| 1989-12-31 | $127.20 Million | $19.00 Million | 0.149x | -86.14% |
| 1985-12-31 | $47.50 Million | $51.20 Million | 1.078x | -- |
About Viatris Inc
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and … Read more